- Home
- Staff Profiles & Phone Book
- About the Department
- Study Anatomy
- Study Neuroscience
- Research
- UCC Anatomical Donations
- Biosciences Imaging Centre
- BSc Medical and Health Sciences
- News & Events
- Contact Us
News Archive 2011
Probiotic bacteria lessens depression...
Probiotic bacteria have the potential to alter brain neurochemistry and treat anxiety and depression-related disorders according to research published today in the prestigious international journal Proceedings of the National Academy of Sciences USA.
“This study identifies potential brain targets and a pathway through which certain gut organisms can alter mouse brain chemistry and behaviour. These findings highlight the important role that gut bacteria play in the bidirectional communication between the gut and the brain, the gut–brain axis, and opens up the intriguing opportunity of developing unique microbial-based strategies for treatment for stress-related psychiatric disorders such as anxiety and depression”, said John F. Cryan, senior author on the publication and Professor of Anatomy and Principal Investigator at the Science Foundation Ireland funded Alimentary Pharmabiotic Centre, at UCC. The APC researchers included Dr Hélène Savignac and Professor Ted Dinan.
The researchers also showed that regular feeding with the Lactobacillus strain caused changes in the expression of receptors for the neurotransmitter GABA in the mouse brain, which is the first time that it has been demonstrated that potential probiotics have a direct effect on brain chemistry in normal situations. The authors also established that the vagus nerve is the main relay between the microbiome (bacteria in the gut) and the brain. This three way communication system is known as the microbiome-gut-brain axis and these findings highlight the important role of bacteria in the communication between the gut and the brain, and suggest that certain probiotic organisms may prove to be useful adjunct therapies in stress-related psychiatric disorders.
Picture: Professor John Cryan, Alimentary Pharmabiotic Centre, UCC